These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 29089233

  • 1. Potential anti-proliferative agents from 1,4-benzoxazinone-quinazolin-4(3H)-one templates.
    Bollu R, Banu S, Kasaboina S, Bantu R, Nagarapu L, Polepalli S, Jain N.
    Bioorg Med Chem Lett; 2017 Dec 15; 27(24):5481-5484. PubMed ID: 29089233
    [Abstract] [Full Text] [Related]

  • 2. Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids.
    Bollu R, Palem JD, Bantu R, Guguloth V, Nagarapu L, Polepalli S, Jain N.
    Eur J Med Chem; 2015 Jan 07; 89():138-46. PubMed ID: 25462234
    [Abstract] [Full Text] [Related]

  • 3. Quinazolinones-Phenylquinoxaline hybrids with unsaturation/saturation linkers as novel anti-proliferative agents.
    Palem JD, Alugubelli GR, Bantu R, Nagarapu L, Polepalli S, Jain SN, Bathini R, Manga V.
    Bioorg Med Chem Lett; 2016 Jul 01; 26(13):3014-3018. PubMed ID: 27209232
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds.
    Mohamed MA, Ayyad RR, Shawer TZ, Abdel-Aziz AA, El-Azab AS.
    Eur J Med Chem; 2016 Apr 13; 112():106-113. PubMed ID: 26890117
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
    Abdel Gawad NM, Georgey HH, Youssef RM, El-Sayed NA.
    Eur J Med Chem; 2010 Dec 13; 45(12):6058-67. PubMed ID: 21051122
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of quinazolin-4(3H)-one derivatives bearing dithiocarbamate side chain at C2-position as potential antitumor agents.
    Ding PP, Gao M, Mao BB, Cao SL, Liu CH, Yang CR, Li ZF, Liao J, Zhao H, Li Z, Li J, Wang H, Xu X.
    Eur J Med Chem; 2016 Jan 27; 108():364-373. PubMed ID: 26703795
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold.
    Mahdavi M, Pedrood K, Safavi M, Saeedi M, Pordeli M, Ardestani SK, Emami S, Adib M, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2015 May 05; 95():492-9. PubMed ID: 25847767
    [Abstract] [Full Text] [Related]

  • 8. Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation.
    Prasad MG, Lakshmi CV, Katari NK, Jonnalagadda SB, Pal M.
    Anticancer Agents Med Chem; 2019 May 05; 19(16):2001-2009. PubMed ID: 31340741
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment.
    Le Y, Gan Y, Fu Y, Liu J, Li W, Zou X, Zhou Z, Wang Z, Ouyang G, Yan L.
    J Enzyme Inhib Med Chem; 2020 Dec 05; 35(1):555-564. PubMed ID: 31967481
    [Abstract] [Full Text] [Related]

  • 10. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
    Abdel-Rahman HM, Abdel-Aziz M, Canzoneri JC, Gary BD, Piazza GA.
    Arch Pharm (Weinheim); 2014 Sep 05; 347(9):650-7. PubMed ID: 24985336
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
    Fan YH, Li W, Liu DD, Bai MX, Song HR, Xu YN, Lee S, Zhou ZP, Wang J, Ding HW.
    Eur J Med Chem; 2017 Oct 20; 139():95-106. PubMed ID: 28800461
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and cytotoxic evaluation of quinazolin-4(3H)-one derivatives bearing thiocarbamate, thiourea or N-methyldithiocarbamate side chains.
    Cao SL, Xu H, Wang Y, Liao J, Zhang JJ, Li ZF, Guo YW, Li XR, Cui XM, Xu X.
    Med Chem; 2012 Mar 20; 8(2):163-73. PubMed ID: 22385175
    [Abstract] [Full Text] [Related]

  • 13. Parallel solution phase synthesis of 3,6,7-4(3H)-quinazolinones and evaluation of their antitumor activities against human cancer.
    Wu H, Xie X, Liu G.
    J Comb Chem; 2010 May 10; 12(3):346-55. PubMed ID: 20196566
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
    El-Azab AS, Abdel-Aziz AA, Ghabbour HA, Al-Gendy MA.
    J Enzyme Inhib Med Chem; 2017 Dec 10; 32(1):1229-1239. PubMed ID: 28948843
    [Abstract] [Full Text] [Related]

  • 15. Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids via the EGFR Inhibition Pathway.
    Hisham M, Hassan HA, Gomaa HAM, Youssif BGM, Hayalah AM, Abdel-Aziz M.
    Anticancer Agents Med Chem; 2023 Dec 10; 23(17):1932-1943. PubMed ID: 37497685
    [Abstract] [Full Text] [Related]

  • 16. Novel quinazolin-4(3H)-one linked to 1,2,3-triazoles: Synthesis and anticancer activity.
    Safavi M, Ashtari A, Khalili F, Mirfazli SS, Saeedi M, Ardestani SK, Rashidi Ranjbar P, Barazandeh Tehrani M, Larijani B, Mahdavi M.
    Chem Biol Drug Des; 2018 Jul 10; 92(1):1373-1381. PubMed ID: 29637699
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition.
    Yang H, Li Q, Su M, Luo F, Liu Y, Wang D, Fan Y.
    Bioorg Med Chem; 2021 Sep 15; 46():116346. PubMed ID: 34403956
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: design, synthesis, QSAR analysis and anticancer activity.
    Alafeefy AM, Ashour AE, Prasad O, Sinha L, Pathak S, Alasmari FA, Rishi AK, Abdel-Aziz HA.
    Eur J Med Chem; 2015 Mar 06; 92():191-201. PubMed ID: 25555142
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity.
    ElZahabi HSA, Nafie MS, Osman D, Elghazawy NH, Soliman DH, El-Helby AAH, Arafa RK.
    Eur J Med Chem; 2021 Oct 15; 222():113609. PubMed ID: 34119830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.